-DOCSTART- -X- O
AIM -X- _ O
: -X- _ O
Chloroquine -X- _ O
is -X- _ O
an -X- _ O
antimalarial -X- _ O
drug -X- _ O
used -X- _ O
in -X- _ O
the -X- _ O
treatment -X- _ O
of -X- _ O
Plasmodium -X- _ B-Patient
vivax -X- _ I-Patient
malaria. -X- _ I-Patient
Three -X- _ O
methods -X- _ O
to -X- _ O
quantify -X- _ O
chloroquine -X- _ B-Intervention
and -X- _ I-Intervention
its -X- _ I-Intervention
metabolite -X- _ I-Intervention
in -X- _ I-Intervention
blood -X- _ I-Intervention
matrices -X- _ I-Intervention
were -X- _ O
developed -X- _ O
and -X- _ O
validated. -X- _ O
METHODOLOGY -X- _ O
& -X- _ O
RESULTS -X- _ O
: -X- _ O
Different -X- _ O
high-throughput -X- _ O
extraction -X- _ O
techniques -X- _ O
were -X- _ O
used -X- _ O
to -X- _ O
recover -X- _ O
the -X- _ O
drugs -X- _ O
from -X- _ O
whole -X- _ B-Comparison
blood -X- _ I-Comparison
( -X- _ I-Comparison
50 -X- _ I-Comparison
μl -X- _ I-Comparison
) -X- _ I-Comparison
, -X- _ I-Comparison
plasma -X- _ I-Comparison
( -X- _ I-Comparison
100 -X- _ I-Comparison
μl -X- _ I-Comparison
) -X- _ I-Comparison
and -X- _ I-Comparison
dried -X- _ I-Comparison
blood -X- _ I-Comparison
spots -X- _ I-Comparison
( -X- _ I-Comparison
15 -X- _ I-Comparison
μl -X- _ I-Comparison
as -X- _ I-Comparison
punched -X- _ I-Comparison
discs -X- _ I-Comparison
) -X- _ I-Comparison
followed -X- _ O
by -X- _ O
quantification -X- _ O
with -X- _ O
LC–MS -X- _ O
/ -X- _ O
MS. -X- _ O
The -X- _ O
intra- -X- _ O
and -X- _ O
inter-batch -X- _ O
precisions -X- _ O
were -X- _ O
below -X- _ O
15 -X- _ O
% -X- _ O
, -X- _ O
and -X- _ O
thus -X- _ O
meet -X- _ O
regulatory -X- _ O
acceptance -X- _ O
criteria. -X- _ O
CONCLUSION -X- _ O
: -X- _ O
The -X- _ O
developed -X- _ O
methods -X- _ O
demonstrated -X- _ O
satisfactory -X- _ B-Outcome
validation -X- _ I-Outcome
performance -X- _ I-Outcome
with -X- _ I-Outcome
high -X- _ I-Outcome
sensitivity -X- _ I-Outcome
and -X- _ I-Outcome
selectivity. -X- _ I-Outcome
The -X- _ I-Outcome
assays -X- _ I-Outcome
used -X- _ I-Outcome
simple -X- _ I-Outcome
and -X- _ I-Outcome
easy -X- _ I-Outcome
to -X- _ I-Outcome
automate -X- _ I-Outcome
extraction -X- _ I-Outcome
techniques. -X- _ I-Outcome
All -X- _ I-Outcome
methods -X- _ I-Outcome
were -X- _ I-Outcome
reliable -X- _ I-Outcome
with -X- _ I-Outcome
robust -X- _ I-Outcome
performance -X- _ I-Outcome
and -X- _ I-Outcome
demonstrated -X- _ I-Outcome
to -X- _ I-Outcome
be -X- _ I-Outcome
suitable -X- _ I-Outcome
to -X- _ I-Outcome
implement -X- _ I-Outcome
into -X- _ I-Outcome
high-throughput -X- _ I-Outcome
routine -X- _ I-Outcome
analysis -X- _ I-Outcome
of -X- _ I-Outcome
clinical -X- _ I-Outcome
pharmacokinetic -X- _ I-Outcome
samples -X- _ I-Outcome
. -X- _ O

